RE: results?27 Aug 2021 18:38
yes read those bothwell and didn't like them either, but i think they are really just the sort of general caveats that they, or their auditors ,require including, to ensure compliance with standards of openness and risk transparency. the problem (amongst numerous other I'm afraid) is that they are perfectly appropriate warnings. ERP will not be immune to a global selloff, but that's just the risk you take with investing in quoted securities. the second warning is i think the most pertinent to us, in that without the cash inflow from Venturex we would have been in need of a cash injection(we still are really but not quite so desperate) and already venturex's s/p has slipped back by 20% or so from the recent highs. for plethora read fortacin and so far as i could see there was no or visually no revenue from sales ,which is hardly surprising if they haven't been able to produce any reliable supplies with working valves etc .tbh to call it a shambles is being generous.i have to accept that covid will have had some impact on supply chains,but surely it's the job of the BOD to address such issues in a way which justifies their salaries etc.this is the life blood of the company and i would expect them to move heaven and earth to address such problems.i realise i may be being unfair and that the problems were simply insurmountable but I'm not convinced this was necessarily the case. personally I'm just relying on the hope that we may get some sort of licensing deal as the fda application progresses, which may enable me to exit with a smaller loss than at present.i would put the chances of this as extremely low,so expecting to be around for a while I'm afraid.